Skip to main content

Pfizer Inc.

corporate_fare Company Profile

Pfizer Inc.

PFE·NYSE·Life Sciences·CIK 0000078003

Pfizer Inc. is a research-based, global biopharmaceutical company that discovers, develops, manufactures, markets, sells, and distributes biopharmaceutical products worldwide. The company applies science and global resources to provide therapies that extend and significantly improve lives. Pfizer operates in both developed and emerging markets, focusing on wellness, prevention, treatments, and cures for significant diseases. It collaborates with healthcare providers, governments, and local communities to support and expand access to reliable, affordable healthcare globally. Incorporated in Delaware on June 2, 1942, Pfizer generates most of its revenues from the manufacture and sale of biopharmaceutical products. The company aims to enhance the value of its medicines and vaccines and works with patients, physicians, and payors to prevent and treat disease and improve outcomes. Pfizer evaluates its pricing arrangements and contracting methods with payors to maximize patient access while minimizing adverse impacts on revenues within current legal and pricing structures.

Pfizer Inc. (NYSE:PFE) is a publicly traded company in the Life Sciences sector. Wiseek monitors PFE SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • German Drug Pricing Policies Jeopardize Pfizer Investment, CEO Warns
  • Pfizer's Acquired Obesity Drug PF-3944 Shows 12.3% Weight Loss, Targets 2028 Approval
  • FDA Expands Pfizer's Hympavzi Approval to New Hemophilia Patient Groups
  • Pfizer's Berobenatide Shows Nearly 16% Weight Loss in Phase 2b, Monthly Dosing Possible
  • Generic Tofacitinib Launches, Threatening Pfizer's Xeljanz; Company Licenses AI for Drug Discovery

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$62.58B
Net Income
$7.77B
Diluted EPS
$1.36
Op. Cash Flow
$11.7B
Free Cash Flow
$9.07B
Gross Profit
$46.51B
Cash & Equivalents
$1.14B
Total Debt
$64.64B
Debt / Equity
0.75×
Net Margin
12.4%
Shares Outstanding
5.68B sh
Source: 10-K · filed 2026-02-26 · accession 0000078003-26-000026
$26.18
52-week range · as of 2026-08-04 $23.11 – $28.75
Market cap
$149.19B
Volume
2M (0.0× avg)
3-mo avg 42.1M
Live data · 2026-08-07 13:38 UTC · Market open

show_chartPrice Chart

Loading chart...

feed PFE - Filings & News (Page 2)

PFE
Jun 10, 2026, 7:16 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $25.71
Real-time Price: $26.18 info
Change: +$0.465 (+2%) info
Market Cap: $149.189B info
PFE
Jun 10, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $25.72
Real-time Price: $26.18 info
Change: +$0.4557 (+2%) info
Market Cap: $149.189B info
PFE
Jun 08, 2026, 6:46 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $25.96
Real-time Price: $26.18 info
Change: +$0.215 (+0.83%) info
Market Cap: $149.189B info
PFE
Jun 06, 2026, 9:04 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $25.95
Real-time Price: $26.18 info
Change: +$0.2245 (+0.87%) info
Market Cap: $149.189B info
PFE
Jun 05, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $25.72
Real-time Price: $26.18 info
Change: +$0.455 (+2%) info
Market Cap: $149.189B info
PFE
Jun 04, 2026, 10:51 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $25.76
Real-time Price: $26.18 info
Change: +$0.420 (+2%) info
Market Cap: $149.189B info
PFE
May 30, 2026, 8:06 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $26.14
Real-time Price: $26.18 info
Change: +$0.035 (+0.13%) info
Market Cap: $149.189B info
PFE
May 30, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $26.14
Real-time Price: $26.18 info
Change: +$0.035 (+0.13%) info
Market Cap: $149.189B info
PFE
May 29, 2026, 8:11 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $26.15
Real-time Price: $26.18 info
Change: +$0.025 (+0.10%) info
Market Cap: $149.189B info
PFE
May 28, 2026, 7:00 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $26.13
Real-time Price: $26.18 info
Change: +$0.045 (+0.17%) info
Market Cap: $149.189B info
PFE
May 20, 2026, 5:05 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $25.62
Real-time Price: $26.18 info
Change: +$0.555 (+2%) info
Market Cap: $149.189B info
PFE
May 13, 2026, 6:46 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $25.80
Real-time Price: $26.18 info
Change: +$0.375 (+1%) info
Market Cap: $149.189B info
PFE
May 05, 2026, 7:03 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $26.48
Real-time Price: $26.18 info
Change: -$0.305 (-1%) info
Market Cap: $149.189B info
PFE
May 05, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $26.49
Real-time Price: $26.18 info
Change: -$0.315 (-1%) info
Market Cap: $149.189B info
PFE
May 05, 2026, 6:56 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $26.35
Real-time Price: $26.18 info
Change: -$0.173 (-0.66%) info
Market Cap: $149.189B info
PFE
May 05, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $26.44
Real-time Price: $26.18 info
Change: -$0.265 (-1%) info
Market Cap: $149.189B info
PFE
Apr 28, 2026, 10:26 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $26.64
Real-time Price: $26.18 info
Change: -$0.460 (-2%) info
Market Cap: $149.189B info
PFE
Apr 02, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $28.33
Real-time Price: $26.18 info
Change: -$2.15 (-8%) info
Market Cap: $149.189B info
PFE
Apr 01, 2026, 11:25 PM EDT
Source: CNBC TV18
Importance Score:
7
Price at Filing: $28.55
Real-time Price: $26.18 info
Change: -$2.38 (-8%) info
Market Cap: $149.189B info
PFE
Apr 01, 2026, 4:09 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $28.54
Real-time Price: $26.18 info
Change: -$2.37 (-8%) info
Market Cap: $149.189B info